KPWKM boosts HPV screening awareness for Orang Asli women
Deputy Minister Datuk Seri Dr Noraini Ahmad highlighted the ministry's commitment to ensuring high-risk groups receive early treatment and accurate health information.
Collaborating with the National Welfare Foundation (YKN) and the National Population and Family Development Board (LPPKN), KPWKM has conducted outreach programmes but faces challenges in reaching remote communities.
'Many Orang Asli women remain unaware of HPV screening. Grassroots efforts are vital to encourage participation in free screenings,' Noraini said during the 'Sentuhan Ilmu dan Khidmat Pakar' CSR event at SK Pos Tenau near Ulu Slim.
The three-day programme, organised by Sultan Azlan Shah Polytechnic (PSAS) with support from government agencies and private firms, aligns with the MADANI agenda to bridge urban-rural healthcare and education gaps.
Noraini noted that early marriage among Orang Asli women often limits their access to lifelong learning opportunities, which community colleges can provide.
The initiative also features the One-Stop Social Support Centre (PSSS), offering mobile social services to underserved communities.
Noraini praised PSAS for integrating technical education with community well-being through STEM activities, health screenings, and family literacy programmes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
a day ago
- Malaysian Reserve
Women's Health Diagnostics Market Hits $14.6 Billion-Kalorama Information Report Reveals Key Growth Drivers to 2030
Comprehensive analysis reveals emerging opportunities in imaging, molecular diagnostics, and AI-driven tools as women's health takes center stage in global care strategies. ARLINGTON, Va., July 17, 2025 /PRNewswire/ — Kalorama Information, a leading healthcare market research firm, has released its latest report, Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030. This in-depth analysis examines the current and projected global markets for diagnostic tests uniquely relevant to women's health, offering vital insights for diagnostic companies, investors, and healthcare stakeholders seeking to capitalize on evolving clinical and consumer needs. As global life expectancy for women continues to rise—and as women account for over 75% of healthcare decision-making in U.S. households—the report emphasizes a critical shift in medical diagnostics toward more personalized, sex-specific tools. Diagnostics are rapidly becoming the backbone of this transformation, enabling earlier detection, better outcomes, and more cost-effective care across the female lifespan. 'The global market for women's health test products is estimated to be worth $14.6 billion in 2024. This arena—once confined to obstetrics and gynecology—now spans specialties such as urology, maternal-fetal medicine, autoimmune and genetic disease,' said Justin Saeks, Senior Analyst at Kalorama Information. 'Diagnostics are essential to connecting patients to the right treatment at the right time, yet they remain one of the most cost-efficient parts of the healthcare system.' Key Takeaways from the Report Rising Global Adoption of NIPT: Non-invasive prenatal testing is now recommended for all U.S. pregnancies and is gaining ground globally. North America accounts for 44% of global NIPT revenues and is projected to grow at 8%+ CAGR through 2029. Mammography Market on the Rise: Driven by widespread breast cancer screening, the mammography systems segment—dominated by digital technology—is forecast to grow at a mid-single-digit CAGR through 2030. AI Transforms Diagnostic Imaging: Advances in deep learning are fueling the growth of computer-aided detection (CAD) tools, projected to expand by nearly 7% annually. Diagnostics Drive Over 70% of Medical Decisions, yet account for less than 5% of total healthcare costs—highlighting a high-impact, under-leveraged sector for innovation and investment. What's Inside the Report The report offers detailed segmentation and forecasts across major diagnostic categories: Imaging: Mammography, OB/GYN ultrasound, CADe/CADx Genetic and Prenatal Testing: NIPT, carrier screening Sexually Transmitted and Infectious Disease: HPV, TORCH, UTI diagnostics Fertility & Pregnancy: POC and lab-based fertility, ovulation, pregnancy testing Cancer and Autoimmune: Pap tests, ovarian cancer biomarkers, autoimmune immunoassays Preventive Diagnostics: Bone densitometry, colposcopy systems Companies Profiled: Becton Dickinson (BD), Hologic, GE HealthCare, Roche, Siemens Healthineers, Thermo Fisher Scientific, and emerging players across key sectors. Who Should Read This Report This report is a must-read for: IVD and Device Manufacturers planning next-gen products in imaging, POC, or molecular diagnostics Pharma and Biotech Firms seeking companion diagnostics for women-targeted therapies Investors and M&A Teams identifying high-growth diagnostic segments Healthcare Providers and Policymakers aiming to close the gap in women's health equity Commercial and Strategy Leaders aligning messaging, product roadmaps, and reimbursement strategies Availability & Contact Information Explore the report: Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030 is available now from Kalorama Information. View Table of Contents / Purchase Report For inquiries and custom consultations:Sheri Davie – Sales For media inquiries:Richa Singh – VP, Strategic & Insights About Kalorama Information Kalorama Information, part of Science and Medicine Group, is a premier source for healthcare market intelligence. For over 25 years, Kalorama has delivered trusted insights on in vitro diagnostics (IVD), clinical testing, and emerging medical technologies, including its industry-leading title, The Worldwide Market for In Vitro Diagnostic Tests. To learn more, visit:
The Star
2 days ago
- The Star
Domestic violence surge spurs action from ministry
Advocates for change: Participant Nor Azila Muda, 47, (centre) holding a sign calling for the elimination of violence against women at the Women's Wellbeing Advocacy Programme @ Domestic Violence (Aku Wanita @ KRT) in Kuala Ibai. — Bernama KUALA TERENGGANU: A total of 2,467 cases of domestic violence were recorded nationwide from January to April this year, most of them involving housewives, says Datuk Seri Dr Noraini Ahmad. The Deputy Women, Family and Community Development Minister said studies showed that most of the abuses were committed by people close to the victim. 'There may be some (victims) who do not even realised they are being abused because the abuse is not just physical, it is emotional. 'Sometimes the perpetrators also use 'reverse psychology',' Noraini said, Bernama reported. 'Studies also found that most abuse is committed by the people closest to the victim or among family members,' she told reporters after launching the Women's Wellbeing Advocacy Programme @ Domestic Violence (Aku Wanita @ KRT) here yesterday. Noraini said that from January to April, 104 cases of domestic violence were recorded in Terengganu. Although the number was a decrease compared to 130 cases recorded during the same period last year, the figure was still worrying, she added. The ministry has started various initiatives to help reduce the number of domestic violence cases, including through the Aku Wanita @ KRT Programme. Through the programme, issues related to domestic violence will be discussed in depth with experts and survivors who will share how they escaped and recovered from abusive relationships. 'In addition, a psychological intervention session called 'K-Chat' has also been introduced through this programme.' The session is a group intervention between survivors with trained counsellors and facilitators to help participants understand and deal with issues that have befallen them due to the abuse, she added.
The Star
3 days ago
- The Star
Namibia moves to tackle HPV vaccine hesitancy amid misinformation
WINDHOEK, July 16 (Xinhua) -- Namibia's Ministry of Health and Social Services on Wednesday addressed concerns over the human papillomavirus (HPV) vaccine, as misinformation, cultural beliefs, and safety fears are hindering public acceptance. The ministry said in a statement that vaccine hesitancy is being fueled by false claims, including concerns about infertility and moral objections, which are not supported by scientific evidence. It urged parents to seek reliable information from healthcare professionals. "The vaccine is safe and effective," the ministry said. "We encourage families and communities to trust verified health sources and support the national rollout." With a population of about 3 million, the southern African nation plans to roll out the HPV vaccine free of charge to girls aged nine to 14 across all 14 regions, with distribution taking place through schools, public health facilities, and targeted outreach initiatives. According to the health ministry, the nationwide education campaign includes community outreach, media engagement, and collaboration with schools to promote awareness about cervical cancer prevention and the benefits of early vaccination. Cervical cancer remains one of the leading causes of cancer-related deaths among women in Namibia, it said, adding that while the HPV vaccine has been available in the private sector since 2007, access has been limited due to its cost and availability. The public sector rollout aims to close the gap and ensure equitable access for all eligible girls, said the ministry. However, it warned that the continued spread of misinformation could undermine the campaign and lead to preventable illness and death. Efforts are underway to address these challenges through accurate public messaging and community engagement, the ministry added.
